U.S. Markets closed

Is McKesson Corporation (MCK) a Great Stock for Value Investors?

Zacks Equity Research

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value?

One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. Let’s put McKesson Corporation MCK stock into this equation and find out if it is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks:

PE Ratio

A key metric that value investors always look at is the Price to Earnings Ratio, or PE for short. This shows us how much investors are willing to pay for each dollar of earnings in a given stock, and is easily one of the most popular financial ratios in the world. The best use of the PE ratio is to compare the stock’s current PE ratio with: a) where this ratio has been in the past; b) how it compares to the average for the industry/sector; and c) how it compares to the market as a whole.

On this front, McKesson Corporation has a trailing twelve months PE ratio of 10.0, as you can see in the chart below:



This level actually compares pretty favorably with the market at large, as the PE for the S&P 500 compares in at about 17.3. If we focus on the stock’s long-term PE trend, the current level puts McKesson Corporation’s current PE ratio slightly below its midpoint (which is 13.5) over the past five years.



Further, the stock’s PE also compares favorably with the industry’s trailing twelve months PE ratio, which stands at 17.7. At the very least, this indicates that the stock is relatively undervalued right now, compared to its peers.



We should also point out that McKesson Corporation has a forward PE ratio (price relative to this year’s earnings) of just 9.9, so it is fair to say that a slightly more value-oriented path may be ahead for McKesson Corporation’s stock in the near term too.

P/S Ratio

Another key metric to note is the Price/Sales ratio. This approach compares a given stock’s price to its total sales, where a lower reading is generally considered better. Some people like this metric more than other value-focused ones because it looks at sales, something that is far harder to manipulate with accounting tricks than earnings.

Right now, McKesson Corporation has a P/S ratio of 0.1. This is significantly lower than the S&P 500 average, which comes in at 3.4 right now. Also, as we can see in the chart below, this is somewhat below the highs for this stock in particular over the past few years.



If anything, this suggests some level of undervalued trading—at least compared to historical norms.   

Broad Value Outlook

In aggregate, McKesson Corporation currently has a Value Style Score of A, putting it into the top 20% of all stocks we cover from this look. This makes MCK a solid choice for value investors, and some of its other key metrics make this pretty clear too.

For example, the PEG ratio for McKesson Corporation is just 1.4, a level that is lower than the industry average of 2.1. The PEG ratio is a modified PE ratio that takes into account the stock’s earnings growth rate. Additionally, its P/CF ratio (another great indicator of value) comes in at 4.8, which is considerably better than the industry average of 16.9. Clearly, MCK is a solid choice on the value front from multiple angles.

What About the Stock Overall?

Though McKesson Corporation might be a good choice for value investors, there are plenty of other factors to consider before investing in this name. In particular, it is worth noting that the company has a Growth grade of F and a Momentum score of D. This gives MCK a VGM score—or its overarching fundamental grade—of C. (You can read more about the Zacks Style Scores here >>)

Meanwhile, the company’s recent earnings estimates have been mixed at best. The current quarter has seen two estimates go higher in the past sixty days and three lower, while the full year estimate has seen eight upward and no downward revisions in the same time period.

This has had a noticeable impact on the consensus estimate, as the current quarter consensus estimate has fallen about 1.9% in the past two months, while the full year estimate has inched up 0.9%. You can see the consensus estimate trend and recent price action for the stock in the chart below:

McKesson Corporation Price and Consensus

 

McKesson Corporation Price and Consensus | McKesson Corporation Quote

Despite this somewhat mixed trend, the stock has a Zacks Rank #2 (Buy) on the back of its strong value metrics and this is why we are expecting above-average performance from the company in the near-term.

Bottom Line

McKesson Corporation is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front. Boasting a good industry rank (top 26% out of more than 250 industries) and a strong Zacks Rank, it is hard to get too excited about this company overall. Nonetheless, over the past one year, the sector has clearly underperformed the broader market, as you can see below:



So, value investors might want to wait for estimates and analyst sentiment factors to turn favorable in this name first, but once that happens, this stock could be a compelling pick.

Zacks' Top 10 Stocks for 2019

In addition to the stocks discussed above, wouldn't you like to know about our 10 finest buy-and-holds for the year?

From more than 4,000 companies covered by the Zacks Rank, these 10 were picked by a process that consistently beats the market. Even during 2018 while the market dropped -5.2%, our Top 10s were up well into double-digits. And during bullish 2012 – 2017, they soared far above the market's +126.3%, reaching +181.9%.

This year, the portfolio features a player that thrives on volatility, an AI comer, and a dynamic tech company that helps doctors deliver better patient outcomes at lower costs.

See Stocks Today >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
McKesson Corporation (MCK) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research